Send feedback

MBD4 p.Pro388Arg

c.1163C>G · rs748834984 · VCV2173823

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.0839 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.47e-05%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.0839likely benign
REVEL0.139moderately benign-leaning
SaProtLLR -6.50tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 2GERP 0.19, phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 8,329 bp · p 0.034 · regional, not allelic
Overall
CADD16.09PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.47e-05% European (non-Finnish) · 1/1,179,974 alleles
Overall 0.000867% 14/1,614,052 alleles · very rare exomes 14/1,461,754 · genomes 0/152,298 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0405% 2,467
Remaining individualsnot grpmax-eligible 0.0016% 62,504
European (non-Finnish)grpmax 8.47e-05% 1,179,974

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MBD4
Protein
p.Pro388Arg
Coding
c.1163C>G
MANE Select
NM_001276270
dbSNP
rs748834984
Type
single nucleotide variant
Location
chr3:129436481 (GRCh38)
Gene constraint
LOEUF 1.023 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 60.67 · 19 PDB
Residue 388
a UniProt-annotated variant site (in tpds2; no mbd4 protein detected by immunohistochemical analysis in patient tumor tissue); a UniProt-annotated variant site (in uvm1); a UniProt-annotated variant site (in tpds2)
Full MBD4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mbd4-p-pro388arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown